Formulation of a mmaA4 Gene Deletion Mutant of Mycobacterium bovis BCG in Cationic Liposomes Significantly Enhances Protection against Tuberculosis

• Steven C. Derrick ,

  * E-mail: steven.derrick@fda.hhs.gov

  Affiliation Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Dee Dao,

  Affiliation Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York, United States of America

  ⨯
• Amy Yang,

  Affiliation Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Kris Kolibab,

  Affiliation Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• William R. Jacobs,

  Affiliation Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York, United States of America

  ⨯
• Sheldon L. Morris

  Affiliation Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯